Action of antimicrobial peptides: two-state model

Current understanding of antimicrobial peptides (AMPs) has focused on their ability to disrupt cell membranes. Prior research has shown that AMPs can insert into lipid bilayers and form pores. However, no prior work had resolved how different AMPs selectively target specific cells. This gap motivated investigations into how membrane composition influences AMP activity. Established knowledge includes the role of peptide-lipid ratios in membrane disruption. Yet, the mechanism explaining variable susceptibility across cell types remained unclear. The two-state model proposed here addresses this uncertainty. It introduces a framework where AMP binding states correlate with cell susceptibility. This paper's contribution lies in connecting lipid composition to AMP activity thresholds.

The aim of this work is to propose a two-state model that explains how antimicrobial peptides interact with cell membranes. The specific problem addressed is the discrepancy between AMP binding affinity and cell susceptibility. The motivation comes from experimental observations that AMPs do not always target cells based on binding strength alone. This model seeks to clarify how AMPs transition from inactive to active states. It also aims to explain why different AMPs prefer certain pathogens. The study focuses on how lipid composition affects AMP thresholds. By identifying a P/L threshold, the model provides a framework for AMP activity prediction. This approach helps explain AMP selectivity and variability in eukaryotic cell lysis.

The study uses a combination of experimental data and theoretical modeling to propose the two-state model. It examines how AMPs interact with lipid bilayers at varying peptide-to-lipid ratios. The model is built on observations of AMP binding states at low and high P/L. Experimental evidence includes measurements of AMP insertion and pore formation. The analysis considers both helical and beta-sheet AMP structures. The lipid composition of cell membranes is a key variable in the model. The study compares AMP activity against different bacterial and eukaryotic cells. This approach allows for a mechanistic explanation of AMP selectivity.

The strongest finding is the identification of two distinct AMP binding states. At low P/L, AMPs remain in an inactive state within the lipid headgroup region. At a threshold P/L, AMPs transition to a multiple-pore state that kills cells. This threshold varies depending on membrane lipid composition. The model explains why AMP susceptibility is not directly linked to binding affinity. It also accounts for why different AMPs target different pathogens. AMPs show varying lytic activity against eukaryotic cells due to membrane differences. The model aligns with experimental data on AMP pore formation. This framework provides a plausible explanation for AMP selectivity and activity variability.

The authors propose that AMP activity depends on a two-state model of membrane binding. This model explains why AMP susceptibility varies with membrane composition. It provides a framework for understanding AMP selectivity across different cells. The findings suggest that AMPs transition from inactive to active states at a P/L threshold. This threshold is determined by the lipid makeup of the cell membrane. The model accounts for why AMPs prefer certain pathogens. It also explains AMP variability in eukaryotic cell lysis. The study concludes that membrane composition is central to AMP activity. These findings support the two-state model as a plausible explanation for AMP function.